articleTop 1% cited
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
The Journal of Urology · 2011 · Vol. 185(5) · pp. 1793–1803
Kevin T. McVary✉(American Urological Association)Claus G. Roehrborn(American Urological Association)Andrew L. Avins(American Urological Association)Michael J. Barry(American Urological Association)Reginald C. Bruskewitz(American Urological Association)Robert F. Donnell(American Urological Association)Harris E. Foster(American Urological Association)Chris M. Gonzalez(American Urological Association)Steven A. Kaplan(American Urological Association)David F. Penson(American Urological Association)James Ulchaker(American Urological Association)John T. Wei(American Urological Association)
Abstract
New pharmacotherapies and technologies have emerged which have impacted treatment algorithms. The management of LUTS/BPH continues to evolve.
Urinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentPharmacology and Obesity TreatmentMedicineGuidelineUrologyHyperplasiaGynecologyProstatic diseaseProstateInternal medicinePathologyCancer
MeSH terms
HumansMaleProstatic HyperplasiaUnited StatesPractice Guidelines as Topic
Citations
1,418
FWCI
81.43
field-weighted impact
References
43
Percentile
100%
vs. same field & year
Citations per year
Cited by
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction
European Urology · 2015 · 984 citations
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
European Urology · 2013 · 1,233 citations
References
UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA
The Journal of Urology · 2005 · 794 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.